Sutro Biopharma SG&A Expense (Quarterly) Analysis

Sutro Biopharma Inc (STRO)

2.785 -0.20 (-6.86%) USD | NASDAQ | Jun 26, 11:10

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	12.72M
December 31, 2023	16.80M
September 30, 2023	15.27M
June 30, 2023	15.00M
March 31, 2023	15.51M
December 31, 2022	14.72M
September 30, 2022	14.64M
June 30, 2022	15.14M
March 31, 2022	15.04M
December 31, 2021	15.76M
September 30, 2021	16.59M
June 30, 2021	12.54M
March 31, 2021	11.11M
December 31, 2020	10.38M

Date	Value
September 30, 2020	9.079M
June 30, 2020	8.643M
March 31, 2020	8.713M
December 31, 2019	8.695M
September 30, 2019	8.115M
June 30, 2019	8.067M
March 31, 2019	7.715M
December 31, 2018	7.574M
September 30, 2018	5.351M
June 30, 2018	4.041M
March 31, 2018	4.414M
December 31, 2017	4.068M
September 30, 2017	4.895M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

8.067M

Minimum

Jun 2019

16.80M

Maximum

Dec 2023

12.63M

Average

13.68M

Median

SG&A Expense (Quarterly) Benchmarks